Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Samuel Gonçalves-Ribeiro, Natalia Guillén Díaz-Maroto, Mireia Berdiel‐Acer, et al.
Oncotarget (2016) Vol. 7, Iss. 37, pp. 59766-59780
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee, Jens Rauch, Walter Kölch
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1102-1102
Open Access | Times Cited: 637
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 446
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy, Chanakya Nath Kundu
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111285-111285
Open Access | Times Cited: 390
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy, Valentin David, Mireille Verdier, et al.
Cancer Science (2020) Vol. 111, Iss. 9, pp. 3142-3154
Open Access | Times Cited: 378
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 304
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
Shamin Azwar, Heng Fong Seow, Maha Abdullah, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 854-854
Open Access | Times Cited: 116
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M. Tilsed, Scott Fisher, Anna K. Nowak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 94
Hydrogel-based colorectal cancer organoid co-culture models
Xiaobei Luo, Eliza Li Shan Fong, Chaojun Zhu, et al.
Acta Biomaterialia (2020) Vol. 132, pp. 461-472
Closed Access | Times Cited: 118
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
Emarndeena H. Cheteh, Martin Augsten, Helene Rundqvist, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 6, pp. e2848-e2848
Open Access | Times Cited: 94
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
Yun Che, Jingnan Wang, Yuan Li, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 7
Open Access | Times Cited: 90
Cancer‐associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells
Limin Wang, Xueqin Li, Yinghui Ren, et al.
Cancer Science (2019) Vol. 110, Iss. 5, pp. 1609-1620
Open Access | Times Cited: 83
Targeting STAT3 Signaling Pathway in Colorectal Cancer
Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1016-1016
Open Access | Times Cited: 68
A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance
Eileen Reidy, Niamh Leonard, Oliver Treacy, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 227-227
Open Access | Times Cited: 62
Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model
Velina S. Atanasova, Crhistian de Jesus Cardona, Václav Hejret, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1391-1419
Open Access | Times Cited: 28
CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer
Sixian Zhu, Jie Mao, Xiaoli Zhang, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 2, pp. 330-342
Closed Access | Times Cited: 25
Cancer-associated fibroblasts in colorectal cancer
Sara Kamali Zonouzi, Parmida Sadat Pezeshki, Sepideh Razi, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 5, pp. 757-769
Closed Access | Times Cited: 46
The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications
Longfei Deng, Nianfen Jiang, Jun Zeng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation
Juan‐kun Liao, Bin Zhou, Xiumei Zhuang, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 1341-1348
Closed Access | Times Cited: 51
Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
Charalampos Fotsitzoudis, Asimina Koulouridi, Ippokratis Messaritakis, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4394-4394
Open Access | Times Cited: 23
Drug Resistance in Cancers: A Free Pass for Bullying
Jing Li, Xiao Li, Qie Guo
Cells (2022) Vol. 11, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 23
Drug-Resistance Biomarkers in Patient-Derived Colorectal Cancer Organoid and Fibroblast Co-Culture System
Kyoung‐Bin Ryu, Jeong-Ah Seo, Kyerim Lee, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5794-5811
Open Access | Times Cited: 4
Involvement of Mitogen-Activated Protein (MAP) Kinase Pathway in the Etiopathogenesis of Cancer and Its Role in Cancer Therapeutics
Nusrat Nabi, Peerzadi Mehakshan Shafat, S. Bashir, et al.
(2025), pp. 43-76
Closed Access
Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
Vijesh Kumar Yadav, Yan‐Jiun Huang, Thomashire A. George, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1590-1590
Open Access | Times Cited: 29
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
Kate Wilkinson, Weng Ng, Tara L. Roberts, et al.
Journal of Clinical Pathology (2021) Vol. 74, Iss. 10, pp. 625-634
Open Access | Times Cited: 25
Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells
Valentina Mele, Camilla Basso, Valeria Governa, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2024-2024
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top